Reaction of 6-amino-3-methyl-4-(substituted phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (1) with triethylorthoformate followed by treatment with hydrazine hydrate, formic acid, acetic acid, phenylisocyanate, ammonium thiocyanate and formamide afforded the corresponding pyranopyrimidine derivatives 2-6. Cyclocondensation of 1 with cyclohexanone afforded pyrazolopyranoquinoline 7. One-pot process of diazotation and de-diazochlorination of 1 afforded pyrazolopyranotriazine derivative 8, which upon treatment with secondary amines afforded 9 and 10a-c. Condensation of 2 with aromatic aldehyde gave the corresponding Schiff bases 11a,b, the oxidative cyclization of the hydrazone with appropriate oxidant afforded 11-(4 -fluorophenyl))-2-(4-substituted phenyl)-10-methyl-8, 11-dihydropyrazolo-[4',3':5,6]pyrano[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines (12a,b). Structures of the synthesized compounds were confirmed by spectral data and elemental analysis. All synthesized compounds were evaluated for antibacterial and antifungal activities compared to norfloxacin and fluconazole as standard drugs. Compounds 9, 10c, 12a and 15 were found to be the most potent antibacterial agents, with activity equal to that of norfloxacin. On the other hand, compound 5 exhibited higher antifungal activity compared to fluconazole.
In continuation of our study of the chemistry of heterocyclic b-enamino-carbonitrile (1) and the synthesis of fused pyrane ring systems of pharmacological importance (2) , pyrane and its fused derivatives have attracted great interest owing to their antimicrobial (3) (4) (5) , antiviral (6) , antitumor (7) , antiproliferactive (8) , molluscicidal (9) , and anti-inflammatory activities (10) . Also, pyrane derivatives are well known antihistaminic agents (11) . moreover, it has been noticed that introduction of an additional ring to the pyrimidine core tends to exert a profound influence in conferring novel biological activities in these molecules (12) (13) (14) . Pyrimidine and their fused derivatives play an essential role in several biological processes and have considerable chemical and pharmacological importance. In particular, pyrimidine nucleus can be found in a broad variety of antibacterial and antitumor agents, as well as in agrochemical and veterinary products (15, 16) . Some substituted pyrano [2,3-c] pyrazoles have been found to be effective antiplatelet molecules (17) , which effect K + -induced calcium-dependent aortal contraction. Several pyrano[2,3-c]-pyrazol-4-ones have demonstrated affinity toward A1 and A2a adenosine receptors (18) . Also, 6-amino-5-cyano-dihydro-pyrano [2,3-c] pyrazoles have been identified as a screening hit for human Chk1 kinase inhibitors (19) . We herein report the use of 6-amino-3-methyl-4-(4-florophenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (1) as starting material for the synthesis of a new series of pyrazolopyranopyrimidines (2) (3) (4) (5) (6) and their derivatives 11a,b, pyrazolopyranoquinoline (7) and pyrazolopyranotriazine (8) .
eXPerimenTAl All melting points were measured on an electrothermal 9100 series digital melting point apparatus (Shimadzu, Japan). microanalytical data were provided by a Vario elementar apparatus (Shimadzu, Japan). Elemental analyses of all compounds were within ± 0.4 % of the theoretical values. Physicochemical data are given in Table I . The IR spectra (Kbr) were recorded on a Perkin elmer 1650 spectrometer (uSA).
1
H spectra were recorded on a JeOl eX-300 and JeOl eCA-500 (Japan). Chemical shifts were expressed in ppm relative to Sime 4 as internal standard in dmSO-d 6 as a solvent. mass spectra were recorded on a 70 eV finnigan SSQ 7000 spectrometer (Thermo-instrument System incorporation, uSA) (Table ii) . The purity of the compounds was checked on aluminium plates coated with silica gel (merck, Germany). Chemicals and solvents were purchased from Sigma-Aldrich (uSA). norfloxacin and fluconazole were supplied by Pasteur laboratory (Giza, egypt). Compound 1 was synthesized according to the reported procedure (20) . [2,3-c] pyrazole-5-carbonitrile (1). -Ethyl-3-(2-carbamo-thioylhydrazineylidene)-butanoate (2.03 g, 10 mmol) was added into sodium ethoxide solution (20 ml) followed by 2-(4-flurobenzylidene)-malononitrile (1.71 g, 10 mmol). The reaction mixture was heated under reflux for 6 h. The compound obtained was crystallized as yellow powder. [4',3':5,6] pyrano [2,3-d] pyrimidin-6(5H)-amine (2) . -Compound 1 (0.01 mol) was added to a mixture of triethylorthoformate (0.01 mol) and acetic anhydride (20 ml) , and the reaction mixture was refluxed for 5 h. The solvent was removed under reduced pressure. The separated solid was refluxed with hydrazine hydrate (0.01 mol) in absolute ethanol (50 ml). The reaction mixture was refluxed for 2 h, concentrated, cooled, and the solid product that separated out was filtered off and recrystallized as yellow powder. [4',3':5,6] pyrano [2,3- ones (3a,b) . General procedure. -A mixture of 1 (0.01 mol) and appropriate acid (formic and/or acetic acid) was refluxed. The solvent was removed under reduced pressure and the separated solid was recrystallized from appropriate solvent in a good yield to give 3a,b respectively. (4) . -Phenyl isocyanate (0.01 mol) and triethylamine (0.5 ml) were added to a solution of 1 (0.01 mol) in ethanol (20 ml). The reaction mixture was refluxed for 3 h, cooled and the resulting solid was filtered off and recrystallized to give 4 as yellow powder. (5) . -Ammonium thiocyanate (0.03 mol) was added to a solution of 1 (0.01 mol) in acetic acid (15 ml) and the reaction mixture was refluxed for 10 h. The solid that separated upon cooling and dilution with water was filtered off and purified to give 5 as pale brown powder. [4',3':5,6] pyrano [2,3-d] pyrimidin5-amine (6) . -Compound 1 (0.01 mol) was added to a mixture of formamide (10 ml), formic acid (5 ml) and dimethylformamide (5 ml). The reaction mixture was refluxed for 12 h. The solid that separated on cooling was filtered off as pale yellow powder. -1,4,6,7,8,9-hexahydropyrazolo[4',3':5,6] pyrano [2,3-b] quinolin-5-amine (7) . -Cyclohexanone (2.8 mmol) was added to a solution of 1 (2 mmol) in a mixture of dichloroethane/THf (2:1). After stirring for 5 min at room temperature, aluminum chloride (4 mmol) was added, and the mixture was heated under reflux for 2 h. The mixture was cooled to room temperature and aluminum chloride (4 mmol) was added. The mixture was refluxed 2 h. The solvent was removed under reduced pressure. An aqueous solution of sodium hydroxide (50 ml, 10 %) was added. After stirring for 30 min, the precipitate was filtered, washed twice with 25 ml of water and with 10 ml of ether, dried at room temperature until constant mass, purified in 5 ml of acetonitrile, and filtered while hot as white powder. [4',3':5,6] pyrano [2,3- (8) . -A solution of sodium nitrite (11.4 mmol) in water (7 ml) was added for 15 min to a suspension of the foregoing compound 1 (8.1 mmol) at 0-5 °C in concentrated hydrochloric acid (16 ml). The resulting mixture was stirred at 0 °C for further 40 min and then allowed to stand at room temperature overnight. The reaction mixture was quenched in water (100 ml). The precipitate was washed twice with 15 ml of water and dried under room temperature, purified in 2 ml of acetonitrile, and filtered while hot to give 8 as orange powder. [4',3':5,6] pyrano [2,3-d] [1, 2, 3] triazines (9, 10a-c) . General procedure.
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-Compound 8 (1 mmol) and the corresponding amine (5 mmol) were fused in a sand bath for 6 h. The mixture was cooled at room temperature and poured into ethanol (30 ml) under stirring. When a precipitate was formed, it was filtered off, washed twice with 15 ml of ethanol and twice with 8 ml of diethyl ether, and then dried at room temperature overnight. [4',3':5,6] [4',3':5,6] pyrano [2,3-d] - [1, 2, 3] triazine (10b) was obtained from 8 with piperazine as brown powder, and [4',3':5,6] pyrano [2,3-d] [1, 2, 3] triazine (10c) was obtained from 8 with N-methylpiperazine as gray powder. [4',3':5,6] pyrano [2,3- 
5-(4-Fluorophenyl)-6-methyl-4-pyrrolidin-1-yl)-5,8-dihydropyrazolo
5-(4-fluorophenyl)-6-methyl-4-meth- ylpiperazin-1-yl)-5,8-dihydropyrazolo
4-(4-Fluorophenyl)-N-[(1Z)-(4-substituted phenyl)methylene]-5-imino-3-methyl-1,4-dihydro-pyrazolo
0 mmol), with appropriate aldehyde (p-fluorobenzaldehyde or 4-methoxy benzaldehyde) (10 mmol), piperidine (0.5 ml) and dioxane (30 ml) was refluxed for 6 hours. The precipitate was filtered off and washed several times with cold etOH. The solid was recrystallized from the appropriate solvent. [4',3':5,6] pyrano [3,2-e] [1, 2, 4] triazolo- [1,5-c] pyrimidine-2(3H)-thione (13) . -To a solution of 2 (0.31 g, 10 mmol in dry pyridine (30 ml), CS 2 (20 mmol) was added and the reaction mixture was heated under reflux for 8 h. After cooling, the reaction mixture was poured onto ice/HCl mixture and the solid that separated was washed with cold water and filtered off to give 13 as yellow powder. (14) . -To a solution of 2 (0.31 g, 10 mmol) in n-buOH, 10 mmol of phathalic acid anhydride was added. The reaction mixture was left overnight and the solid that formed (14) was collected as pale brown powder. (15) . -A solution of 2 (0.31 g, 10 mmol) in dioxane (10 ml) was stirred with isatin (15 mmol) for 24 hours at room temperature. The product that separated out (15) as orange powder was filtered off.
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2-[4-(4-Fluorophenyl)-5-imino-3-methyl-1,4-dihydropyrazolo[4',3':5,6]pyrano[2,3-d]pyrimi- din-6(5H)-yl]-1H-isoindole-1,3(2H)-dione(2z)-2-{[4-(4-fluorophenyl)-5-imino-3-methyl-1,4-dihydropyrazolo[4',3':5,6]-pyrano[2,3-d] pyrimidin-6(5H)-yl]imino}-1,2-dihydro-3H-indol-3-one
Pharmacological screening
Antimicrobial activity. -Antimicrobial activities of the newly synthesized compounds were tested in vitro for activity against the following bacteria: Gram-positive bacteria Streptococcus lactis NCTC-1030, Staphylococcus aureus NCTC-4493, Enterococcus faecalis NCTC-4737, Gram-negative bacteria Escherichia coli ATCC-1416, Pseudomonas aeruginosa ATCC-2642, Klebsiella pneumoniae ATCC-1081, and fungal strains Candida albicans ATCC-14154, Aspergillus flavus ATCC-23554 and Ganoderma lucidum ATCC-33455. All microorganisms were purchased from the American Type Culture Collection (manassas, uSA). The newly synthesized compounds (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) were dissolved in dmSO and tested for antimicrobial activity with the agar disk diffusion technique (21), using a 1-cm microplate-well diameter and a solution of 100 mg ml -1 of the test compound. Compound-impregnated disks were placed on an agar plate containing a standard suspension of microorganisms. The plate was incubated for 24 h at 37 °C. Diameters of the zones of inhibition were measured with calipers or automated scanners and were compared with those of the standards. norfloxacin (0.16 mmol ml ) and fluconazole (6.5 x 10 -3 mmol ml
) were used as reference drugs for antibacterial and antifungal activity, respectively.
for determination of minimum inhibitory concentrations (MIC) (22) by the serial plate dilution method, 5 mg of each test compound was dissolved in 1 ml of dimethylsulfoxide (dmSO) to prepare the stock solution. Serial dilutions were prepared from the stock solution. The plates were incubated at 37 °C for 24 h. MIC was the lowest concentration (mmol ml ) of the test compound that resulted in no visible growth on the plates. dmSO was used as a solvent control to ensure that the solvent had no effect on bacterial growth. The results of antimicrobial activities are summarized in Tables I and II. reSulTS And diSCuSSiOn
Chemistry
The bifunctional compound 1 was used for the synthesis of pyrazolopyranopyrimidine derivatives by the reaction with different reagents. Thus, the treatment of 6-amino-3- (8) appeared when compound 8 was subject to the action of secondary amine, namely, pyrole, morpholine, piperazine and N-methylpiperazine. The chlorine atom was displaced to form the corresponding compounds 9 and 10a-c, respectively (Scheme 2).
According to the literature (25, 26) , compounds having azomethine linkage exhibit E/Z geometrical isomerism around C=N double bond and can exist as cis/trans amide conformers (26) . moreover, hydrazones were proven to exist in higher percentage in dmSO-d 6 solution in the form of geometrical E isomers. Thus, compound 2 on treatment with the appropriate aromatic aldehyde, namely p-fluorobenzaldehyde/anisaldehyde, by refluxing with ethanol in the presence of a catalytic amount of piperidine gave 4-(4-fluorophenyl)- amines (11a,b) . Also, nmr spectra of compounds 11 recorded in dmSO-d 6 solution revealed that all compounds existed as E geometrical isomers. Oxidative cyclization of the resultant hydrazone derivatives 11a,b to 12a,b was achieved by using alumina-supported calcium hypochlorite (Ca(OCl) 2 for instance, a maximum yield of 73 % for 12a and 75 % for 12b in 2 h was achieved with the 1:3 molar ratio of hydrazone to calcium hypochlorite. The use of alumina-supported calcium hypochlorite as a heterogeneous oxidant in this reaction has the advantage of an enhanced reaction rate and yield (see Scheme 3). in the present work, we wish to point out the reaction of hydrazino derivative 2 with phthalic anhydride. When compound 2 with phthalic anhydride in an oil bath, it yielded 2-phthalimidoamino derivative 14. The reaction took place via acylation of hydrazino moiety by phthalic anhydride, followed by ring closure to give the desired product. On the other hand, stirring of compound 2 with isatin at room temperature yielded compound 15 (Scheme 4). The structure of the resultant compound was fully established by spectral data, which included IR, 
Antimicrobial screening and SAR
The minimum inhibitory concentration values (MICs) against different Gram-positive, Gram-negative bacteria and fungi were tested. The investigations showed significant inhibitory effects against bacteria with the majority of the compounds with MIC values of 1-21 mmol ml -1 (Table III) . The antibacterial data indicated that compounds 2, 3a,b, 4, 5, 6, 11a,b, 13 and 14 displayed good activity against all tested bacteria. This activity can be attributed to the presence of pyrimidine moiety. Compound 2 comprised iminopyrimidine with amino group attached at N-3, compounds 3a,b are pyrimidone derivatives, while compounds 4, 5 are 6 are 4-amino pyrimidine and pyrimidine thione derivatives. Compounds 11a,b contain N-hydrazonyl, 13 triazolo thione and 14 N-isoindol dione pyrimidine moieties. Evaluation of the antibacterial activity of synthesized compounds 7 and 8 revealed that compounds were effective against all tested bacteria due to the presence of tetrahydroquinoline moiety in 7 and 4-chlorotriazine in 8. Regarding the antibacterial activities, pyrazolopyranotriazine derivatives 9 and 10a-c were the most active compounds; their MIC values were 1-5 mmol ml -1 against Gram-positive and 3-8 mmol ml 
